🔗 Visit the ClinicalTrials.gov page for NCT00887107
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. | Eur J Endocrinol | 2009 | 1.78 |
| 2 | Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. | J Clin Endocrinol Metab | 2010 | 1.72 |
| 3 | Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma. | PLoS One | 2012 | 0.92 |